What does CUSIP 56565P103 represent in this 13F holders report?

CUSIP 56565P103 is the security identifier for MPLT - MapLight Therapeutics, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held MPLT - MapLight Therapeutics, Inc. - COMMON STOCK in Q4 2025?

74 institutional investors reported MPLT - MapLight Therapeutics, Inc. - COMMON STOCK for Q4 2025. Use the holders table for investor-level position and value details.

MapLight Therapeutics, Inc. - COMMON STOCK (MPLT)

CUSIP: 56565P103

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / COMMON STOCK
Shares outstanding: 45,148,065
Total 13F shares: 23,065,711
Share change: +23,062,256
Total reported value: $405,121,994
Price per share: $17.56
Number of holders: 74
Value change: +$405,061,184
Number of buys: 73

Quarterly Holders Quick Answers

What is CUSIP 56565P103?
CUSIP 56565P103 identifies MPLT - MapLight Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2026

Recent filing periods for CUSIP 56565P103:

Q1 2026 Q4 2025

Top shareholders of MPLT - MapLight Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Catalyst4, Inc.	13D/G 3/4/5	10%+ Owner	45%	19,697,464	$361,842,414	$0	28 Oct 2025	13D/G 3/4/5
Forbion Growth Opportunities Fund III Cooperatief U.A.	13D/G	—	7.1%	3,226,400	$61,527,448	$0	31 Dec 2025	13D/G
T. Rowe Price Investment Management, Inc.	13D/G	—	6.2%	2,799,180	$53,380,363	$0	31 Dec 2025	13D/G
Novo Holdings A/S	3/4/5 13D/G	10%+ Owner	8.4% from 13D/G	3,686,622	—	—	28 Oct 2025	3/4/5 13D/G
Maria C. Walker	3/4/5	Director	— mixed-class rows	31,898 mixed-class rows	—	—	27 Oct 2025	3/4/5

Institutional Holders of MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) as of Q4 2025

As of 31 Dec 2025, MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,065,711 shares. The largest 10 holders included NOVO HOLDINGS A/S, FCPM III SERVICES B.V., T. Rowe Price Investment Management, Inc., GOLDMAN SACHS GROUP INC, BlackRock, Inc., Nan Fung Group Holdings Ltd, 5AM Venture Management, LLC, Sanofi, VANGUARD GROUP INC, and Pivotal bioVenture Partners Investment Advisor LLC. This page lists 74 institutional shareholders reporting positions in this security for the Q4 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2025 vs Q4 2025 Across Filers

Q4 2025 holders

Holder diff

Investor	Q4 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q4 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.